The angiotensin II type 2 receptor in cardiovascular disease

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 11, Issue 1, 2010, Pages 19-31

  Lemarié, Catherine A ^a   Schiffrin, Ernesto L ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Apoptosis; AT2 receptor; Endothelial function; Growth; Hypertension; Intracellular signalling; Vascular remodelling

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; ARACHIDONIC ACID; BRADYKININ; CANDESARTAN HEXETIL; CYCLIC GMP; LOSARTAN; NITRIC OXIDE; PHOSPHOLIPASE A2; PHOSPHOPROTEIN PHOSPHATASE; VALSARTAN;

APOPTOSIS; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CELL GROWTH; DRUG MECHANISM; DRUG SCREENING; HORMONE ACTION; HUMAN; HYPERTENSION; HYPERTROPHY; INFLAMMATION; LOW DRUG DOSE; MUSCLE GROWTH; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN DEPHOSPHORYLATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIGNAL TRANSDUCTION; VASODILATATION;

ANIMALS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; HUMANS; RECEPTOR, ANGIOTENSIN, TYPE 2; SIGNAL TRANSDUCTION; VASODILATION;

EID: 77749273905     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.1177/1470320309347785     Document Type: Review

References (115)

1. Henrion D., Kubis N., Levy BI Physiological and pathophysiological functions of the AT(2) subtype receptor of angiotensin II: from large arteries to the microcirculation. Hypertension 2001 ; 38: 1150-1157.
2. Miura S., Karnik SS Ligand-independent signals from angiotensin II type 2 receptor induce apoptosis. EMBO J 2000 ; 19: 4026-4035.
3. Levy BI, Benessiano J., Henrion D. et al. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure. J Clin Invest 1996 ; 98: 418-425.
4. Matsubara H. Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ Res 1998 ; 83: 1182-1191.
5. Savoia C., Schiffrin EL Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions. Clin Sci (Lond) 2007 ; 112: 375-384.
6. Allen AM, Zhuo J., Mendelsohn FA Localization and function of angiotensin AT1 receptors. Am J Hypertens 2000 ; 13: 31S - 38S.
7. Siragy HM The role of the AT2 receptor in hypertension. Am J Hypertens 2000 ; 13: 62S - 67S.
8. Touyz RM, Schiffrin EL Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev 2000 ; 52: 639-672.
9. Katada J., Majima M. AT(2) receptor-dependent vasodilation is mediated by activation of vascular kinin generation under flow conditions. Br J Pharmacol 2002 ; 136: 484-491.
10. Liu YH, Yang XP, Sharov VG et al. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors. J Clin Invest 1997 ; 99: 1926-1935.
11. Seyedi N., Xu X., Nasjletti A., Hintze TH Coronary kinin generation mediates nitric oxide release after angiotensin receptor stimulation. Hypertension 1995 ; 26: 164-170.
12. Tanaka M., Tsuchida S., Imai T. et al. Vascular response to angiotensin II is exaggerated through an upregulation of AT1 receptor in AT2 knockout mice. Biochem Biophys Res Commun 1999 ; 258: 194-198.
13. Wiemer G., Scholkens BA, Wagner A., Heitsch H., Linz W. The possible role of angiotensin II subtype AT2 receptors in endothelial cells and isolated ischemic rat hearts. J Hypertens Suppl 1993 ; 11: S234-5.
14. Tsutsumi Y., Matsubara H., Masaki H. et al. Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. J Clin Invest 1999 ; 104: 925-935.
15. Bergaya S., Hilgers RH, Meneton P. et al. Flow-dependent dilation mediated by endogenous kinins requires angiotensin AT2 receptors. Circ Res 2004 ; 94: 1623-1629.
16. Abadir PM, Periasamy A., Carey RM, Siragy HM Angiotensin II type 2 receptor-bradykinin B2 receptor functional heterodimerization. Hypertension 2006 ; 48: 316-322.
17. AbdAlla S., Lother H., Abdel-tawab AM, Quitterer U. The angiotensin II AT2 receptor is an AT1 receptor antagonist. J Biol Chem 2001 ; 276: 39721-39726.
18. Akishita M., Yamada H., Dzau VJ, Horiuchi M. Increased vasoconstrictor response of the mouse lacking angiotensin II type 2 receptor. Biochem Biophys Res Commun 1999 ; 261: 345-349.
19. Ichiki T., Labosky PA, Shiota C. et al. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 1995 ; 377: 748-750.
20. Siragy HM, Inagami T., Ichiki T., Carey RM Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor. Proc Natl Acad Sci U S A 1999 ; 96: 6506-6510.
21. Cox BE, Word RA, Rosenfeld CR Angiotensin II receptor characteristics and subtype expression in uterine arteries and myometrium during pregnancy. J Clin Endocrinol Metab 1996 ; 81: 49-58.
22. Endo Y., Arima S., Yaoita H., Tsunoda K., Omata K., Ito S. Vasodilation mediated by angiotensin II type 2 receptor is impaired in afferent arterioles of young spontaneously hypertensive rats. J Vasc Res 1998 ; 35: 421-427.
23. Hayashi K., Suzuki H., Saruta T. Segmental differences in angiotensin receptor subtypes in interlobular artery of hydronephrotic rat kidneys. Am J Physiol 1993 ; 265: F881-5.
24. Matrougui K., Levy BI, Henrion D. Tissue angiotensin II and endothelin-1 modulate differently the response to flow in mesenteric resistance arteries of normotensive and spontaneously hypertensive rats. Br J Pharmacol 2000 ; 130: 521-526.
25. Touyz RM, Endemann D., He G., Li JS, Schiffrin EL Role of AT2 receptors in angiotensin II-stimulated contraction of small mesenteric arteries in young SHR. Hypertension 1999 ; 33: 366-372.
26. Zwart AS, Davis EA, Widdop RE Modulation of AT1 receptor-mediated contraction of rat uterine artery by AT2 receptors. Br J Pharmacol 1998 ; 125: 1429-1436.
27. Widdop RE, Matrougui K., Levy BI, Henrion D. AT2 receptor-mediated relaxation is preserved after long-term AT1 receptor blockade. Hypertension 2002 ; 40: 516-520.
28. Savoia C., Tabet F., Yao G., Schiffrin EL, Touyz RM Negative regulation of RhoA/Rho kinase by angiotensin II type 2 receptor in vascular smooth muscle cells: role in angiotensin II-induced vasodilation in stroke-prone spontaneously hypertensive rats. J Hypertens 2005 ; 23: 1037-1045.
29. Savoia C., Touyz RM, Volpe M., Schiffrin EL Angiotensin type 2 receptor in resistance arteries of type 2 diabetic hypertensive patients. Hypertension 2007 ; 49: 341-346.
30. Sampson AK, Moritz KM, Jones ES, Flower RL, Widdop RE, Denton KM Enhanced angiotensin II type 2 receptor mechanisms mediate decreases in arterial pressure attributable to chronic low-dose angiotensin II in female rats. Hypertension 2008 ; 52: 666-671.
31. Booz GW, Baker KM Role of type 1 and type 2 angiotensin receptors in angiotensin II-induced cardiomyocyte hypertrophy. Hypertension 1996 ; 28: 635-640.
32. Diep QN, Li JS, Schiffrin EL In vivo study of AT(1) and AT(2) angiotensin receptors in apoptosis in rat blood vessels. Hypertension 1999 ; 34: 617-624.
33. Horiuchi M., Akishita M., Dzau VJ Recent progress in angiotensin II type 2 receptor research in the cardiovascular system. Hypertension 1999 ; 33: 613-621.
34. Adachi Y., Saito Y., Kishimoto I. et al. Angiotensin II type 2 receptor deficiency exacerbates heart failure and reduces survival after acute myocardial infarction in mice. Circulation 2003 ; 107: 2406-2408.
35. Suzuki J., Iwai M., Nakagami H. et al. Role of angiotensin II-regulated apoptosis through distinct AT1 and AT2 receptors in neointimal formation. Circulation 2002 ; 106: 847-853.
36. Wu L., Iwai M., Nakagami H. et al. Roles of angiotensin II type 2 receptor stimulation associated with selective angiotensin II type 1 receptor blockade with valsartan in the improvement of inflammation-induced vascular injury. Circulation 2001 ; 104: 2716-2721.
37. Peters S., Gotting B., Trummel M., Rust H., Brattstrom A. Valsartan for prevention of restenosis after stenting of type B2/C lesions: the VAL-PREST trial. J Invasive Cardiol 2001 ; 13: 93-97.
38. Peters S., Trummel M., Meyners W., Koehler B., Westermann K. Valsartan versus ACE inhibition after bare metal stent implantation-results of the VALVACE trial. Int J Cardiol 2005 ; 98: 331-335.
39. Akishita M., Iwai M., Wu L. et al. Inhibitory effect of angiotensin II type 2 receptor on coronary arterial remodeling after aortic banding in mice. Circulation 2000 ; 102: 1684-1689.
40. Brede M., Hadamek K., Meinel L. et al. Vascular hypertrophy and increased P70S6 kinase in mice lacking the angiotensin II AT(2) receptor. Circulation 2001 ; 104: 2602-2607.
41. Hutchinson HG, Hein L., Fujinaga M., Pratt RE Modulation of vascular development and injury by angiotensin II. Cardiovasc Res 1999 ; 41: 689-700.
42. Nakajima M., Hutchinson HG, Fujinaga M. et al. The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer. Proc Natl Acad Sci U S A 1995 ; 92: 10663-10667.
43. Wu L., Iwai M., Nakagami H. et al. Effect of angiotensin II type 1 receptor blockade on cardiac remodeling in angiotensin II type 2 receptor null mice. Arterioscler Thromb Vasc Biol 2002 ; 22: 49-54.
44. Yamamoto Y., Watari Y., Brydun A. et al. Role of the angiotensin II type 2 receptor in arterial remodeling after wire injury in mice. Hypertens Res 2008 ; 31: 1241-1249.
45. Gallinat S., Busche S., Raizada MK, Sumners C. The angiotensin II type 2 receptor: an enigma with multiple variations. Am J Physiol Endocrinol Metab 2000 ; 278: E357-74.
46. Yamada T., Horiuchi M., Dzau VJ Angiotensin II type 2 receptor mediates programmed cell death. Proc Natl Acad Sci U S A 1996 ; 93: 156-160.
47. Goldenberg I., Grossman E., Jacobson KA, Shneyvays V., Shainberg A. Angiotensin II-induced apoptosis in rat cardiomyocyte culture: a possible role of AT1 and AT2 receptors. J Hypertens 2001 ; 19: 1681-1689.
48. Ding G., Reddy K., Kapasi AA et al. Angiotensin II induces apoptosis in rat glomerular epithelial cells. Am J Physiol Renal Physiol 2002 ; 283: F173-80.
49. Bhaskaran M., Reddy K., Radhakrishanan N., Franki N., Ding G., Singhal PC Angiotensin II induces apoptosis in renal proximal tubular cells. Am J Physiol Renal Physiol 2003 ; 284: F955-65.
50. Tea BS, Der SS, Touyz RM, Hamet P., deBlois D. Proapoptotic and growth-inhibitory role of angiotensin II type 2 receptor in vascular smooth muscle cells of spontaneously hypertensive rats in vivo. Hypertension 2000 ; 35: 1069-1073.
51. Bascands JL, Girolami JP, Troly M. et al. Angiotensin II induces phenotype-dependent apoptosis in vascular smooth muscle cells. Hypertension 2001 ; 38: 1294-1299.
52. Moudgil R., Musat-Marcu S., Xu Y., Kumar D., Jugdutt BI Increased AT(2)R protein expression but not increased apoptosis during cardioprotection induced by AT(1)R blockade. Can J Cardiol 2002 ; 18: 1107-1116.
53. Sugino H., Ozono R., Kurisu S. et al. Apoptosis is not increased in myocardium overexpressing type 2 angiotensin II receptor in transgenic mice. Hypertension 2001 ; 37: 1394-1398.
54. Dimmeler S., Rippmann V., Weiland U., Haendeler J., Zeiher AM Angiotensin II induces apoptosis of human endothelial cells. Protective effect of nitric oxide. Circ Res 1997 ; 81: 970-976.
55. Schneider MD, Lorell BH AT(2), judgment day: which angiotensin receptor is the culprit in cardiac hypertrophy? Circulation 2001 ; 104: 247-248.
56. Zhu YC, Zhu YZ, Lu N., Wang MJ, Wang YX, Yao T. Role of angiotensin AT1 and AT2 receptors in cardiac hypertrophy and cardiac remodelling. Clin Exp Pharmacol Physiol 2003 ; 30: 911-918.
57. Booz GW Putting the brakes on cardiac hypertrophy: exploiting the NO-cGMP counter-regulatory system. Hypertension 2005 ; 45: 341-346.
58. van Kesteren CA, van Heugten HA, Lamers JM, Saxena PR, Schalekamp MA, Danser AH Angiotensin II-mediated growth and antigrowth effects in cultured neonatal rat cardiac myocytes and fibroblasts. J Mol Cell Cardiol 1997 ; 29: 2147-2157.
59. Ichihara S., Senbonmatsu T., Price E. Jr, Ichiki T., Gaffney FA, Inagami T. Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension. Circulation 2001 ; 104: 346-351.
60. Senbonmatsu T., Ichihara S., Price E. Jr, Gaffney FA, Inagami T. Evidence for angiotensin II type 2 receptor-mediated cardiac myocyte enlargement during in vivo pressure overload. J Clin Invest 2000 ; 106: R25-9.
61. Kurisu S., Ozono R., Oshima T. et al. Cardiac angiotensin II type 2 receptor activates the kinin/NO system and inhibits fibrosis. Hypertension 2003 ; 41: 99-107.
62. Falcon BL, Stewart JM, Bourassa E. et al. Angiotensin II type 2 receptor gene transfer elicits cardioprotective effects in an angiotensin II infusion rat model of hypertension. Physiol Genomics 2004 ; 19: 255-261.
63. Metcalfe BL, Huentelman MJ, Parilak LD et al. Prevention of cardiac hypertrophy by angiotensin II type-2 receptor gene transfer. Hypertension 2004 ; 43: 1233-1238.
64. Yan X., Schuldt AJ, Price RL et al. Pressure overload-induced hypertrophy in transgenic mice selectively overexpressing AT2 receptors in ventricular myocytes. Am J Physiol Heart Circ Physiol 2008 ; 294: H1274-81.
65. Marchesi C., Paradis P., Schiffrin EL Role of the renin-angiotensin system in vascular inflammation. Trends Pharmacol Sci 2008 ; 29: 367-374.
66. Ruiz-Ortega M., Lorenzo O., Suzuki Y., Ruperez M., Egido J. Proinflammatory actions of angiotensins. Curr Opin Nephrol Hypertens 2001 ; 10: 321-329.
67. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999 ; 340: 115-126.
68. Prasad A., Koh KK, Schenke WH et al. Role of angiotensin II type 1 receptor in the regulation of cellular adhesion molecules in atherosclerosis. Am Heart J 2001 ; 142: 248-253.
69. Ruiz-Ortega M., Lorenzo O., Ruperez M., Blanco J., Egido J. Systemic infusion of angiotensin II into normal rats activates nuclear factor-kappaB and AP-1 in the kidney: role of AT(1) and AT(2) receptors. Am J Pathol 2001 ; 158: 1743-1756.
70. Vongpatanasin W., Thomas GD, Schwartz R. et al. C-reactive protein causes downregulation of vascular angiotensin subtype 2 receptors and systolic hypertension in mice. Circulation 2007 ; 115: 1020-1028.
71. Sales VL, Sukhova GK, Lopez-Ilasaca MA, Libby P., Dzau VJ, Pratt RE Angiotensin type 2 receptor is expressed in murine atherosclerotic lesions and modulates lesion evolution. Circulation 2005 ; 112: 3328-3336.
72. Iwai M., Chen R., Li Z. et al. Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice. Circulation 2005 ; 112: 1636-1643.
73. Daugherty A., Rateri DL, Lu H., Inagami T., Cassis LA Hypercholesterolemia stimulates angiotensin peptide synthesis and contributes to atherosclerosis through the AT1A receptor. Circulation 2004 ; 110: 3849-3857.
74. Dahlof B., Devereux RB, Kjeldsen SE et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002 ; 359: 995-1003. (Pubitemid 34286536)
75. Lithell H., Hansson L., Skoog I. et al. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertens 2003 ; 21: 875-886. (Pubitemid 36677151)
76. Nishimura Y., Ito T., Saavedra JM Angiotensin II AT(1) blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats. Stroke 2000 ; 31: 2478-2486.
77. Zhou J., Pavel J., Macova M. et al. AT1 receptor blockade regulates the local angiotensin II system in cerebral microvessels from spontaneously hypertensive rats. Stroke 2006 ; 37: 1271-1276.
78. Iwai M., Liu HW, Chen R. et al. Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation. Circulation 2004 ; 110: 843-848.
79. Iwanami J., Mogi M., Li JM et al. Deletion of angiotensin II type 2 receptor attenuates protective effects of bone marrow stromal cell treatment on ischemia-reperfusion brain injury in mice. Stroke 2008 ; 39: 2554-2559.
80. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000 ; 6: 389-395.
81. Silvestre JS, Tamarat R., Senbonmatsu T. et al. Antiangiogenic effect of angiotensin II type 2 receptor in ischemia-induced angiogenesis in mice hindlimb. Circ Res 2002 ; 90: 1072-1079.
82. Papapetropoulos A., Desai KM, Rudic RD et al. Nitric oxide synthase inhibitors attenuate transforming-growth-factor-beta 1-stimulated capillary organization in vitro. Am J Pathol 1997 ; 150: 1835-1844.
83. Tamarat R., Silvestre JS, Durie M., Levy BI Angiotensin II angiogenic effect in vivo involves vascular endothelial growth factor- and inflammation-related pathways. Lab Invest 2002 ; 82: 747-756.
84. Benndorf R., Boger RH, Ergun S., Steenpass A., Wieland T. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells. Circ Res 2003 ; 93: 438-447.
85. de Gasparo M., Catt KJ, Inagami T., Wright JW, Unger T. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 2000 ; 52: 415-472.
86. Mogi M., Iwai M., Horiuchi M. Emerging concepts of regulation of angiotensin II receptors: new players and targets for traditional receptors. Arterioscler Thromb Vasc Biol 2007 ; 27: 2532-2539.
87. Stoll M., Unger T. Angiotensin and its AT2 receptor: new insights into an old system. Regul Pept 2001 ; 99: 175-182.
88. Johren O., Dendorfer A., Dominiak P. Cardiovascular and renal function of angiotensin II type-2 receptors. Cardiovasc Res 2004 ; 62: 460-467.
89. Jacobs LS, Douglas JG Angiotensin II type 2 receptor subtype mediates phospholipase A2-dependent signaling in rabbit proximal tubular epithelial cells. Hypertension 1996 ; 28: 663-668.
90. Lokuta AJ, Cooper C., Gaa ST, Wang HE, Rogers TB Angiotensin II stimulates the release of phospholipid-derived second messengers through multiple receptor subtypes in heart cells. J Biol Chem 1994 ; 269: 4832-4838.
91. Richmond RS, Tallant EA, Gallagher PE, Ferrario CM, Strawn WB Angiotensin II stimulates arachidonic acid release from bone marrow stromal cells. J Renin Angiotensin Aldosterone Syst 2004 ; 5: 176-182.
92. Zhu M., Gelband CH, Moore JM, Posner P., Sumners C. Angiotensin II type 2 receptor stimulation of neuronal delayed-rectifier potassium current involves phospholipase A2 and arachidonic acid. J Neurosci 1998 ; 18: 679-686.
93. Guilluy C., Rolli-Derkinderen M., Loufrani L. et al. Ste20-related kinase SLK phosphorylates Ser188 of RhoA to induce vasodilation in response to angiotensin II type 2 receptor activation. Circ Res 2008 ; 102: 1265-1274.
94. Cui T., Nakagami H., Iwai M. et al. Pivotal role of tyrosine phosphatase SHP-1 in AT2 receptor-mediated apoptosis in rat fetal vascular smooth muscle cell. Cardiovasc Res 2001 ; 49: 863-871.
95. Horiuchi M., Hayashida W., Kambe T., Yamada T., Dzau VJ Angiotensin type 2 receptor dephosphorylates Bcl-2 by activating mitogen-activated protein kinase phosphatase-1 and induces apoptosis. J Biol Chem 1997 ; 272: 19022-19026.
96. Huang XC, Richards EM, Sumners C. Mitogen-activated protein kinases in rat brain neuronal cultures are activated by angiotensin II type 1 receptors and inhibited by angiotensin II type 2 receptors. J Biol Chem 1996 ; 271: 15635-15641.
97. Cui TX, Nakagami H., Nahmias C. et al. Angiotensin II subtype 2 receptor activation inhibits insulin-induced phosphoinositide 3-kinase and Akt and induces apoptosis in PC12W cells. Mol Endocrinol 2002 ; 16: 2113-2123.
98. Matsubara H., Shibasaki Y., Okigaki M. et al. Effect of angiotensin II type 2 receptor on tyrosine kinase Pyk2 and c-Jun NH2-terminal kinase via SHP-1 tyrosine phosphatase activity: evidence from vascular-targeted transgenic mice of AT2 receptor. Biochem Biophys Res Commun 2001 ; 282: 1085-1091.
99. Shibasaki Y., Matsubara H., Nozawa Y. et al. Angiotensin II type 2 receptor inhibits epidermal growth factor receptor transactivation by increasing association of SHP-1 tyrosine phosphatase. Hypertension 2001 ; 38: 367-372.
100. De Paolis P., Porcellini A., Savoia C. et al. Functional crosstalk between angiotensin II and epidermal growth factor receptors in NIH3T3 fibroblasts. J Hypertens 2002 ; 20: 693-699.
101. Elbaz N., Bedecs K., Masson M., Sutren M., Strosberg AD, Nahmias C. Functional trans-inactivation of insulin receptor kinase by growth-inhibitory angiotensin II AT2 receptor. Mol Endocrinol 2000 ; 14: 795-804.
102. Carey RM, Howell NL, Jin XH, Siragy HM Angiotensin type 2 receptor-mediated hypotension in angiotensin type-1 receptor-blocked rats. Hypertension 2001 ; 38: 1272-1277.
103. de Godoy MA, de Oliveira AM, Rattan S. Angiotensin II-induced relaxation of anococcygeus smooth muscle via desensitization of AT1 receptor, and activation of AT2 receptor associated with nitric-oxide synthase pathway. J Pharmacol Exp Ther 2004 ; 311: 394-401.
104. Andresen BT, Shome K., Jackson EK, Romero GG AT2 receptors cross talk with AT1 receptors through a nitric oxide-and RhoA-dependent mechanism resulting in decreased phospholipase D activity. Am J Physiol Renal Physiol 2005 ; 288: F763-70.
105. Miura S., Karnik SS, Saku K. Constitutively active homo-oligomeric angiotensin II type 2 receptor induces cell signaling independent of receptor conformation and ligand stimulation. J Biol Chem 2005 ; 280: 18237-18244.
106. Ruiz-Ortega M., Lorenzo O., Ruperez M., Konig S., Wittig B., Egido J. Angiotensin II activates nuclear transcription f actor kappaB through AT(1) and AT(2) in vascular smooth muscle cells: molecular mechanisms. Circ Res 2000 ; 86: 1266-1272.
107. Han Y., Runge MS, Brasier AR Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-kappa B transcription factors. Circ Res 1999 ; 84: 695-703.
108. Wolf G., Ziyadeh FN, Thaiss F. et al. Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells. Role of the angiotensin type 2 receptor. J Clin Invest 1997 ; 100: 1047-1058.
109. Klahr S., Morrissey JJ The role of vasoactive compounds, growth factors and cytokines in the progression of renal disease. Kidney Int Suppl 2000 ; 75: S7-14.
110. Bockaert J., Marin P., Dumuis A., Fagni L. The ?magic tail? of G protein-coupled receptors: an anchorage for functional protein networks. FEBS Lett 2003 ; 546: 65-72.
111. Marinissen MJ, Gutkind JS G-protein-coupled receptors and signaling networks: emerging paradigms. Trends Pharmacol Sci 2001 ; 22: 368-376.
112. Nouet S., Amzallag N., Li JM et al. Trans-inactivation of receptor tyrosine kinases by novel angiotensin II AT2 receptor-interacting protein, ATIP. J Biol Chem 2004 ; 279: 28989-28997.
113. Wruck CJ, Funke-Kaiser H., Pufe T. et al. Regulation of transport of the angiotensin AT2 receptor by a novel membrane-associated Golgi protein. Arterioscler Thromb Vasc Biol 2005 ; 25: 57-64.
114. Senbonmatsu T., Saito T., Landon EJ et al. A novel angiotensin II type 2 receptor signaling pathway: possible role in cardiac hypertrophy. EMBO J 2003 ; 22: 6471-6482.
115. Barber MN, Sampey DB, Widdop RE AT(2) receptor stimulation enhances antihypertensive effect of AT(1) receptor antagonist in hypertensive rats. Hypertension 1999 ; 34: 1112-1116.